|
|
Volumn 23, Issue 4, 2009, Pages 266-272
|
|
Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ARTICLE;
COMPARATIVE STUDY;
DIABETIC RETINOPATHY;
DRUG ANTAGONISM;
EYE FUNDUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INJECTION;
LASER COAGULATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
RETROSPECTIVE STUDY;
RISK FACTOR;
TREATMENT OUTCOME;
VITREORETINOPATHY;
VITREOUS BODY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
DIABETIC RETINOPATHY;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
FUNDUS OCULI;
HUMANS;
INJECTIONS;
LASER COAGULATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RISK FACTORS;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VITREORETINOPATHY, PROLIFERATIVE;
VITREOUS BODY;
|
|
EID: 77949881577
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2009.23.4.266 Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
